Hlača, N., Žagar, T., Kaštelan, M., Peternel, S., Brajac, I., Dujmović‐Hasanbegović, K. & Prpić‐Massari, L. (2022). Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine. Dermatologic Therapy, 35. (11). doi: 10.1111/dth.15791
Hlača, Nika, et al. "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine." Dermatologic Therapy, vol. 35, no. 11, 2022. https://doi.org/10.1111/dth.15791
Hlača, Nika, Tina Žagar, Marija Kaštelan, Sandra Peternel, Ines Brajac, Katarina Dujmović‐Hasanbegović and Larisa Prpić‐Massari. "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine." Dermatologic Therapy 35, no. 11 (2022). https://doi.org/10.1111/dth.15791
Hlača, N., et al. (2022) 'Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine', Dermatologic Therapy, 35(11). doi: 10.1111/dth.15791
Hlača N, Žagar T, Kaštelan M, Peternel S, Brajac I, Dujmović‐Hasanbegović K, and sur.. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine. Dermatologic Therapy [Internet]. 2022 September 07 [cited 2024 December 27];35(11). doi: 10.1111/dth.15791
N. Hlača, et al., "Pityriasis rubra pilaris following booster dose of mRNA (Pfizer–
BioNTech) COVID-19 vaccine", Dermatologic Therapy, vol. 35, no. 11, September 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:387055. [Accessed: 27 December 2024]